share_log

HC Wainwright & Co. Maintains Buy on Dynavax Technologies, Lowers Price Target to $27

Benzinga ·  Feb 24, 2023 06:17

HC Wainwright & Co. analyst Edward White maintains Dynavax Technologies (NASDAQ:DVAX) with a Buy and lowers the price target from $28 to $27.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment